Market Overview:
The global tetanus human monoclonal antibody market is expected to grow at a CAGR of 7.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing prevalence of tetanus, rising demand for monoclonal antibodies for research activities, and growing investments in the healthcare sector. Based on type, the global tetanus human monoclonal antibody market is segmented into light chain antibodies, heavy chain antibodies, mouse antibodies, goat antibodies, and others. The light chain antibody segment is expected to account for the largest share of the global market in 2018. This segment is projected to grow at a CAGR of 8% during the forecast period from 2018 to 2030. The large share of this segment can be attributed to its high usage in medical applications and growing demand for these types of antibodies from research laboratories across the globe. Based on application,the global tetanus human monoclonal antibody market is divided into medical applications and research activities segments.
Product Definition:
Tetanus human monoclonal antibody is a protein that is used to treat tetanus. The importance of tetanus human monoclonal antibody is that it can help to prevent the spread of the disease and can also help to reduce symptoms.
Light Chain Antibodies:
Light chain antibodies are also known as anti-IgM or antibody, which is the first type of antibody produced by an immune system in response to an antigen. It is a type of immunoglobulin that plays a key role in neutralizing and removing pathogens from the body.
Heavy Chain Antibodies:
Heavy chain antibodies are used in Tetanus Human Monoclonal Antibody (THMA) diagnosis and treatment. They are also known as anti-tetanus human antibodies or antitetanus immunoglobulin. These molecules consist of an heavy (IgM) or light (IgD) chain and a variable domain. The antibody is formed by the immune system in response to the antigen that is present in bacteria, spores, dust, food products, etc.
Application Insights:
Medical application dominated the global market in 2017. The medical segment is expected to witness a CAGR of XX% over the forecast period owing to an increase in tetanus cases across various regions, including Africa and Asia Pacific. According to WHO, around 20 million people get affected by lockjaw every year globally and about 200,000 die due to this condition which needs immediate treatment.
The research activities segment held a significant share of the global market in 2017 as it has been proven that monoclonal antibodies are effective for research purposes only and cannot be used therapeutically for treating patients with tetanus infection as they would not recognize the self-toxin present within their bodies leading to ineffective therapy outcomes.
Regional Analysis:
North America dominated the global market in 2017. The presence of key players, advanced healthcare infrastructure and high investment by governments for research activities are some factors responsible for its large share. Moreover, increasing incidence oflockjaw and other acute neurologic disorders due to lack of immunization is expected to drive the demand further.
Asia Pacific region is anticipated to witness lucrative growth over the forecast period owing to rising disposable income coupled with growing medical tourism in emerging economies such as India and China. In addition, increasing prevalence of tetanus infection due to lack of immunization programs will also boost regional market growth during the forecast period.
Growth Factors:
- Increasing incidence of tetanus across the globe
- Growing demand for monoclonal antibodies for diagnosis and treatment of tetanus
- Rising number of research and development activities focused on monoclonal antibody therapeutics for tetanus
- Technological advancements in the field of monoclonal antibody production that are expected to reduce manufacturing costs
- increasing investments by pharmaceutical companies in the development of novel therapies for treating tetanus
Scope Of The Report
Report Attributes
Report Details
Report Title
Tetanus Human Monoclonal Antibody Market Research Report
By Type
Light Chain Antibodies, Heavy Chain Antibodies, Mouse Antibodies, Goat Antibodies, Others
By Application
Medical, Research Activities, Other
By Companies
Antagen Pharmaceuticals, Thermo Fisher Scientific, BioScience, Colorado Serum Company, Bio-Rad, Abcam, GSK Canada, Hypermunes, MSD
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
168
Number of Tables & Figures
118
Customization Available
Yes, the report can be customized as per your need.
Global Tetanus Human Monoclonal Antibody Market Report Segments:
The global Tetanus Human Monoclonal Antibody market is segmented on the basis of:
Types
Light Chain Antibodies, Heavy Chain Antibodies, Mouse Antibodies, Goat Antibodies, Others
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Medical, Research Activities, Other
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Antagen Pharmaceuticals
- Thermo Fisher Scientific
- BioScience
- Colorado Serum Company
- Bio-Rad
- Abcam
- GSK Canada
- Hypermunes
- MSD
Highlights of The Tetanus Human Monoclonal Antibody Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Light Chain Antibodies
- Heavy Chain Antibodies
- Mouse Antibodies
- Goat Antibodies
- Others
- By Application:
- Medical
- Research Activities
- Other
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Tetanus Human Monoclonal Antibody Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
A tetanus human monoclonal antibody is a type of antibody that is made from the blood of someone who has had tetanus. This type of antibody can help protect people from getting tetanus, and it is also used to diagnose and treat other diseases.
Some of the major players in the tetanus human monoclonal antibody market are Antagen Pharmaceuticals, Thermo Fisher Scientific, BioScience, Colorado Serum Company, Bio-Rad, Abcam, GSK Canada, Hypermunes, MSD.
The tetanus human monoclonal antibody market is expected to grow at a compound annual growth rate of 7.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Tetanus Human Monoclonal Antibody Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Tetanus Human Monoclonal Antibody Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Tetanus Human Monoclonal Antibody Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Tetanus Human Monoclonal Antibody Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Tetanus Human Monoclonal Antibody Market Size & Forecast, 2020-2028
4.5.1 Tetanus Human Monoclonal Antibody Market Size and Y-o-Y Growth
4.5.2 Tetanus Human Monoclonal Antibody Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Light Chain Antibodies
5.2.2 Heavy Chain Antibodies
5.2.3 Mouse Antibodies
5.2.4 Goat Antibodies
5.2.5 Others
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Medical
6.2.2 Research Activities
6.2.3 Other
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Tetanus Human Monoclonal Antibody Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Tetanus Human Monoclonal Antibody Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Light Chain Antibodies
9.6.2 Heavy Chain Antibodies
9.6.3 Mouse Antibodies
9.6.4 Goat Antibodies
9.6.5 Others
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Medical
9.10.2 Research Activities
9.10.3 Other
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Light Chain Antibodies
10.6.2 Heavy Chain Antibodies
10.6.3 Mouse Antibodies
10.6.4 Goat Antibodies
10.6.5 Others
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Medical
10.10.2 Research Activities
10.10.3 Other
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Light Chain Antibodies
11.6.2 Heavy Chain Antibodies
11.6.3 Mouse Antibodies
11.6.4 Goat Antibodies
11.6.5 Others
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Medical
11.10.2 Research Activities
11.10.3 Other
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Light Chain Antibodies
12.6.2 Heavy Chain Antibodies
12.6.3 Mouse Antibodies
12.6.4 Goat Antibodies
12.6.5 Others
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Medical
12.10.2 Research Activities
12.10.3 Other
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Light Chain Antibodies
13.6.2 Heavy Chain Antibodies
13.6.3 Mouse Antibodies
13.6.4 Goat Antibodies
13.6.5 Others
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Medical
13.10.2 Research Activities
13.10.3 Other
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Tetanus Human Monoclonal Antibody Market: Competitive Dashboard
14.2 Global Tetanus Human Monoclonal Antibody Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Antagen Pharmaceuticals
14.3.2 Thermo Fisher Scientific
14.3.3 BioScience
14.3.4 Colorado Serum Company
14.3.5 Bio-Rad
14.3.6 Abcam
14.3.7 GSK Canada
14.3.8 Hypermunes
14.3.9 MSD
